Endothelin receptor antagonists as antihypertensives: the next frontier.
about
Endothelin, hypertension and chronic kidney disease: new insights.ETA activation mediates angiotensin II-induced infiltration of renal cortical T cells.Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia.Involvement of imidazoline and opioid receptors in the enhancement of clonidine-induced analgesia by sulfisoxazole.A Mediterranean diet supplemented with extra virgin olive oil or nuts improves endothelial markers involved in blood pressure control in hypertensive women.
P2860
Endothelin receptor antagonists as antihypertensives: the next frontier.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Endothelin receptor antagonists as antihypertensives: the next frontier.
@en
Endothelin receptor antagonists as antihypertensives: the next frontier.
@nl
type
label
Endothelin receptor antagonists as antihypertensives: the next frontier.
@en
Endothelin receptor antagonists as antihypertensives: the next frontier.
@nl
prefLabel
Endothelin receptor antagonists as antihypertensives: the next frontier.
@en
Endothelin receptor antagonists as antihypertensives: the next frontier.
@nl
P2860
P356
P1476
Endothelin receptor antagonists as antihypertensives: the next frontier.
@en
P2093
Benjamin J Epstein
Shawn Anderson
P2860
P304
P356
10.1586/ERC.09.24
P577
2009-06-01T00:00:00Z